<VariationArchive VariationID="424774" VariationName="NM_003494.3(DYSF):c.[3516_3517delTT];[5078G&gt;A]" VariationType="CompoundHeterozygote" Accession="VCV000424774" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2015-10-11" MostRecentSubmission="2015-10-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <Genotype VariationID="424774">
      <SimpleAllele AlleleID="213540" VariationID="217226">
        <GeneList>
          <Gene Symbol="DYSF" FullName="dysferlin" GeneID="8291" HGNC_ID="HGNC:3097" Source="submitted" RelationshipType="within single gene">
            <Location>
              <CytogeneticLocation>2p13.2</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="71453561" stop="71686763" display_start="71453561" display_stop="71686763" Strand="+" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="71680752" stop="71913892" display_start="71680752" display_stop="71913892" Strand="+" />
            </Location>
            <OMIM>603009</OMIM>
          </Gene>
        </GeneList>
        <Name>NM_001130987.2(DYSF):c.3570_3571del (p.Phe1190_Ser1191insTer)</Name>
        <CanonicalSPDI>NC_000002.12:71590280:TTTTT:TTT</CanonicalSPDI>
        <VariantType>Deletion</VariantType>
        <Location>
          <CytogeneticLocation>2p13.2</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="71590281" stop="71590282" display_start="71590281" display_stop="71590282" variantLength="2" positionVCF="71590280" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="71817411" stop="71817412" display_start="71817411" display_stop="71817412" variantLength="2" positionVCF="71817410" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
        </Location>
        <HGVSlist>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.71817414_71817415del" Assembly="GRCh37">
              <Expression>NC_000002.11:g.71817414_71817415del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.71590284_71590285del" Assembly="GRCh38">
              <Expression>NC_000002.12:g.71590284_71590285del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_008694.1" sequenceAccession="NG_008694" sequenceVersion="1" change="g.141662_141663del">
              <Expression>NG_008694.1:g.141662_141663del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130455.2" sequenceAccession="NM_001130455" sequenceVersion="2" change="c.3519_3520del">
              <Expression>NM_001130455.2:c.3519_3520del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001123927.1" sequenceAccession="NP_001123927" sequenceVersion="1" change="p.Phe1173_Ser1174insTer">
              <Expression>NP_001123927.1:p.Phe1173_Ser1174insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130976.2" sequenceAccession="NM_001130976" sequenceVersion="2" change="c.3474_3475del">
              <Expression>NM_001130976.2:c.3474_3475del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001124448.1" sequenceAccession="NP_001124448" sequenceVersion="1" change="p.Phe1158_Ser1159insTer">
              <Expression>NP_001124448.1:p.Phe1158_Ser1159insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130977.2" sequenceAccession="NM_001130977" sequenceVersion="2" change="c.3474_3475del">
              <Expression>NM_001130977.2:c.3474_3475del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001124449.1" sequenceAccession="NP_001124449" sequenceVersion="1" change="p.Phe1158_Ser1159insTer">
              <Expression>NP_001124449.1:p.Phe1158_Ser1159insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130978.2" sequenceAccession="NM_001130978" sequenceVersion="2" change="c.3516_3517del">
              <Expression>NM_001130978.2:c.3516_3517del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001124450.1" sequenceAccession="NP_001124450" sequenceVersion="1" change="p.Phe1172_Ser1173insTer">
              <Expression>NP_001124450.1:p.Phe1172_Ser1173insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130979.2" sequenceAccession="NM_001130979" sequenceVersion="2" change="c.3609_3610del">
              <Expression>NM_001130979.2:c.3609_3610del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001124451.1" sequenceAccession="NP_001124451" sequenceVersion="1" change="p.Phe1203_Ser1204insTer">
              <Expression>NP_001124451.1:p.Phe1203_Ser1204insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130980.2" sequenceAccession="NM_001130980" sequenceVersion="2" change="c.3567_3568del">
              <Expression>NM_001130980.2:c.3567_3568del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001124452.1" sequenceAccession="NP_001124452" sequenceVersion="1" change="p.Phe1189_Ser1190insTer">
              <Expression>NP_001124452.1:p.Phe1189_Ser1190insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130981.2" sequenceAccession="NM_001130981" sequenceVersion="2" change="c.3567_3568del">
              <Expression>NM_001130981.2:c.3567_3568del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001124453.1" sequenceAccession="NP_001124453" sequenceVersion="1" change="p.Phe1189_Ser1190insTer">
              <Expression>NP_001124453.1:p.Phe1189_Ser1190insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130982.2" sequenceAccession="NM_001130982" sequenceVersion="2" change="c.3612_3613del">
              <Expression>NM_001130982.2:c.3612_3613del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001124454.1" sequenceAccession="NP_001124454" sequenceVersion="1" change="p.Phe1204_Ser1205insTer">
              <Expression>NP_001124454.1:p.Phe1204_Ser1205insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130983.2" sequenceAccession="NM_001130983" sequenceVersion="2" change="c.3519_3520del">
              <Expression>NM_001130983.2:c.3519_3520del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001124455.1" sequenceAccession="NP_001124455" sequenceVersion="1" change="p.Phe1173_Ser1174insTer">
              <Expression>NP_001124455.1:p.Phe1173_Ser1174insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130984.2" sequenceAccession="NM_001130984" sequenceVersion="2" change="c.3477_3478del">
              <Expression>NM_001130984.2:c.3477_3478del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001124456.1" sequenceAccession="NP_001124456" sequenceVersion="1" change="p.Phe1159_Ser1160insTer">
              <Expression>NP_001124456.1:p.Phe1159_Ser1160insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130985.2" sequenceAccession="NM_001130985" sequenceVersion="2" change="c.3570_3571del">
              <Expression>NM_001130985.2:c.3570_3571del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001124457.1" sequenceAccession="NP_001124457" sequenceVersion="1" change="p.Phe1190_Ser1191insTer">
              <Expression>NP_001124457.1:p.Phe1190_Ser1191insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130986.2" sequenceAccession="NM_001130986" sequenceVersion="2" change="c.3477_3478del">
              <Expression>NM_001130986.2:c.3477_3478del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001124458.1" sequenceAccession="NP_001124458" sequenceVersion="1" change="p.Phe1159_Ser1160insTer">
              <Expression>NP_001124458.1:p.Phe1159_Ser1160insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130987.2" sequenceAccession="NM_001130987" sequenceVersion="2" change="c.3570_3571del" MANESelect="true">
              <Expression>NM_001130987.2:c.3570_3571del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001124459.1" sequenceAccession="NP_001124459" sequenceVersion="1" change="p.Phe1190_Ser1191insTer">
              <Expression>NP_001124459.1:p.Phe1190_Ser1191insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_003494.4" sequenceAccession="NM_003494" sequenceVersion="4" change="c.3516_3517del" MANEPlusClinical="true">
              <Expression>NM_003494.4:c.3516_3517del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_003485.1" sequenceAccession="NP_003485" sequenceVersion="1" change="p.Phe1172_Ser1173insTer">
              <Expression>NP_003485.1:p.Phe1172_Ser1173insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="LRG_845" sequenceAccession="LRG_845">
              <Expression>LRG_845:g.141662_141663del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="LRG_845t2" sequenceAccession="LRG_845t2">
              <Expression>LRG_845t2:c.3570_3571del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="LRG_845p2" sequenceAccession="LRG_845p2" change="p.Phe1190_Ser1191insTer">
              <Expression>LRG_845p2:p.Phe1190_Ser1191insTer</Expression>
            </ProteinExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="LRG_845t1" sequenceAccession="LRG_845t1">
              <Expression>LRG_845t1:c.3516_3517del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="LRG_845p1" sequenceAccession="LRG_845p1" change="p.Phe1172_Ser1173insTer">
              <Expression>LRG_845p1:p.Phe1172_Ser1173insTer</Expression>
            </ProteinExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_003494.4" sequenceAccession="NM_003494" sequenceVersion="4" change="c.3516_3517delTT" MANEPlusClinical="true">
              <Expression>NM_003494.4:c.3516_3517delTT</Expression>
            </NucleotideExpression>
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification DateLastEvaluated="2023-12-23" DateCreated="2015-10-16" MostRecentSubmission="2024-06-13" NumberOfSubmissions="7" NumberOfSubmitters="7">
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description>Pathogenic</Description>
            <Citation Type="general">
              <ID Source="PubMed">16010686</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">17562833</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">17698709</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">20544924</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">21522182</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">22616201</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">25591676</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">27229680</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">27858744</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">28403181</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">34559919</ID>
            </Citation>
            <Citation Type="general">
              <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=DYSF</URL>
            </Citation>
            <Citation Type="review" Abbrev="GeneReviews">
              <ID Source="PubMed">20301480</ID>
              <ID Source="BookShelf">NBK1303</ID>
            </Citation>
            <ConditionList>
              <TraitSet ID="9586" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="9484" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">Dysferlinopathy</ElementValue>
                    <XRef ID="Dysferlinopathy/2379" DB="Genetic Alliance" />
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Qualitative or quantitative defects of dysferlin</ElementValue>
                    <XRef ID="MONDO:0016145" DB="MONDO" />
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">Dysferlinopathy includes a spectrum of muscle disease characterized by two major phenotypes: Miyoshi muscular dystrophy (MMD) and limb-girdle muscular dystrophy type 2B (LGMD2B); and two minor phenotypes: asymptomatic hyperCKemia and distal myopathy with anterior tibial onset (DMAT). MMD (median age of onset 19 years) is characterized by muscle weakness and atrophy, most marked in the distal parts of the legs, especially the gastrocnemius and soleus muscles. Over a period of years, the weakness and atrophy spread to the thighs and gluteal muscles. The forearms may become mildly atrophic with decrease in grip strength; the small muscles of the hands are spared. LGMD2B is characterized by early weakness and atrophy of the pelvic and shoulder girdle muscles in adolescence or young adulthood, with slow progression. Other phenotypes in this spectrum are scapuloperoneal syndrome and congenital muscular dystrophy. Asymptomatic hyperCKemia is characterized by marked elevation of serum CK concentration only. DMAT is characterized by early and predominant distal muscle weakness, particularly of the muscles of the anterior compartment of the legs.</Attribute>
                    <XRef ID="NBK1303" DB="GeneReviews" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="2003" />
                    <XRef ID="2003" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301480</ID>
                    <ID Source="BookShelf">NBK1303</ID>
                  </Citation>
                  <XRef ID="207073" DB="Orphanet" />
                  <XRef ID="C2931687" DB="MedGen" />
                  <XRef ID="MONDO:0016145" DB="MONDO" />
                </Trait>
              </TraitSet>
              <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="17556" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">none provided</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">not provided</ElementValue>
                    <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
                  </AttributeSet>
                  <XRef ID="C3661900" DB="MedGen" />
                </Trait>
              </TraitSet>
              <TraitSet ID="12373" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="9521" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy</ElementValue>
                    <XRef ID="MONDO:0015152" DB="MONDO" />
                  </Name>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="19825" />
                    <XRef ID="19825" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <XRef ID="102015" DB="Orphanet" />
                  <XRef ID="C2931907" DB="MedGen" />
                  <XRef ID="MONDO:0015152" DB="MONDO" />
                  <XRef Type="Phenotypic series" ID="PS253600" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="1850" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="2988" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2B</ElementValue>
                    <XRef ID="Limb-girdle+muscular+dystrophy%2C+type+2B/4237" DB="Genetic Alliance" />
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2B</ElementValue>
                    <XRef ID="MONDO:0009676" DB="MONDO" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 2</ElementValue>
                    <XRef Type="MIM" ID="253601" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0003" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0012" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0004" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0017" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0016" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0006" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0013" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0005" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0008" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0009" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0019" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0020" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0007" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0021" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0014" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0022" DB="OMIM" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Muscular dystrophy, limb-girdle, type 3</ElementValue>
                  </Name>
                  <Symbol>
                    <ElementValue Type="Preferred">LGMDR2</ElementValue>
                    <XRef Type="MIM" ID="253601" DB="OMIM" />
                  </Symbol>
                  <Symbol>
                    <ElementValue Type="Alternate">LGMD3</ElementValue>
                    <XRef Type="MIM" ID="253601" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="public definition">Dysferlinopathy includes a spectrum of muscle disease characterized by two major phenotypes: Miyoshi muscular dystrophy (MMD) and limb-girdle muscular dystrophy type 2B (LGMD2B); and two minor phenotypes: asymptomatic hyperCKemia and distal myopathy with anterior tibial onset (DMAT). MMD (median age of onset 19 years) is characterized by muscle weakness and atrophy, most marked in the distal parts of the legs, especially the gastrocnemius and soleus muscles. Over a period of years, the weakness and atrophy spread to the thighs and gluteal muscles. The forearms may become mildly atrophic with decrease in grip strength; the small muscles of the hands are spared. LGMD2B is characterized by early weakness and atrophy of the pelvic and shoulder girdle muscles in adolescence or young adulthood, with slow progression. Other phenotypes in this spectrum are scapuloperoneal syndrome and congenital muscular dystrophy. Asymptomatic hyperCKemia is characterized by marked elevation of serum CK concentration only. DMAT is characterized by early and predominant distal muscle weakness, particularly of the muscles of the anterior compartment of the legs.</Attribute>
                    <XRef ID="NBK1303" DB="GeneReviews" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="8574" />
                    <XRef ID="8574" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301480</ID>
                    <ID Source="BookShelf">NBK1303</ID>
                  </Citation>
                  <XRef ID="268" DB="Orphanet" />
                  <XRef ID="C1850889" DB="MedGen" />
                  <XRef ID="MONDO:0009676" DB="MONDO" />
                  <XRef Type="MIM" ID="253601" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="1848" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="2959" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Miyoshi muscular dystrophy 1</ElementValue>
                    <XRef ID="MONDO:0024545" DB="MONDO" />
                    <XRef ID="C118846" DB="NCI" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Preferred">MMD1</ElementValue>
                    <XRef Type="MIM" ID="254130" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="public definition">Dysferlinopathy includes a spectrum of muscle disease characterized by two major phenotypes: Miyoshi muscular dystrophy (MMD) and limb-girdle muscular dystrophy type 2B (LGMD2B); and two minor phenotypes: asymptomatic hyperCKemia and distal myopathy with anterior tibial onset (DMAT). MMD (median age of onset 19 years) is characterized by muscle weakness and atrophy, most marked in the distal parts of the legs, especially the gastrocnemius and soleus muscles. Over a period of years, the weakness and atrophy spread to the thighs and gluteal muscles. The forearms may become mildly atrophic with decrease in grip strength; the small muscles of the hands are spared. LGMD2B is characterized by early weakness and atrophy of the pelvic and shoulder girdle muscles in adolescence or young adulthood, with slow progression. Other phenotypes in this spectrum are scapuloperoneal syndrome and congenital muscular dystrophy. Asymptomatic hyperCKemia is characterized by marked elevation of serum CK concentration only. DMAT is characterized by early and predominant distal muscle weakness, particularly of the muscles of the anterior compartment of the legs.</Attribute>
                    <XRef ID="NBK1303" DB="GeneReviews" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="keyword">Miyoshi Distal Myopathy</Attribute>
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301480</ID>
                    <ID Source="BookShelf">NBK1303</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="AAN, 2017">
                    <ID Source="PubMed">25313375</ID>
                    <ID Source="pmc">4206155</ID>
                  </Citation>
                  <XRef ID="45448" DB="Orphanet" />
                  <XRef ID="C4551973" DB="MedGen" />
                  <XRef ID="MONDO:0024545" DB="MONDO" />
                  <XRef Type="MIM" ID="254130" DB="OMIM" />
                </Trait>
              </TraitSet>
            </ConditionList>
          </GermlineClassification>
        </Classifications>
        <XRefList>
          <XRef Type="Interpreted" ID="424774" DB="ClinVar" />
          <XRef ID="CA279106" DB="ClinGen" />
          <XRef Type="rs" ID="766341386" DB="dbSNP" />
        </XRefList>
      </SimpleAllele>
      <SimpleAllele AlleleID="213541" VariationID="242527">
        <GeneList>
          <Gene Symbol="DYSF" FullName="dysferlin" GeneID="8291" HGNC_ID="HGNC:3097" Source="submitted" RelationshipType="within single gene">
            <Location>
              <CytogeneticLocation>2p13.2</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="71453561" stop="71686763" display_start="71453561" display_stop="71686763" Strand="+" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="71680752" stop="71913892" display_start="71680752" display_stop="71913892" Strand="+" />
            </Location>
            <OMIM>603009</OMIM>
          </Gene>
        </GeneList>
        <Name>NM_001130987.2(DYSF):c.5195G&gt;A (p.Arg1732Gln)</Name>
        <CanonicalSPDI>NC_000002.12:71665181:G:A</CanonicalSPDI>
        <VariantType>single nucleotide variant</VariantType>
        <Location>
          <CytogeneticLocation>2p13.2</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="71665182" stop="71665182" display_start="71665182" display_stop="71665182" variantLength="1" positionVCF="71665182" referenceAlleleVCF="G" alternateAlleleVCF="A" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="71892312" stop="71892312" display_start="71892312" display_stop="71892312" variantLength="1" positionVCF="71892312" referenceAlleleVCF="G" alternateAlleleVCF="A" />
        </Location>
        <ProteinChange>R1693Q</ProteinChange>
        <ProteinChange>R1732Q</ProteinChange>
        <ProteinChange>R1701Q</ProteinChange>
        <ProteinChange>R1714Q</ProteinChange>
        <ProteinChange>R1715Q</ProteinChange>
        <ProteinChange>R1724Q</ProteinChange>
        <ProteinChange>R1694Q</ProteinChange>
        <ProteinChange>R1710Q</ProteinChange>
        <ProteinChange>R1711Q</ProteinChange>
        <ProteinChange>R1725Q</ProteinChange>
        <ProteinChange>R1679Q</ProteinChange>
        <ProteinChange>R1680Q</ProteinChange>
        <ProteinChange>R1700Q</ProteinChange>
        <ProteinChange>R1731Q</ProteinChange>
        <HGVSlist>
          <HGVS Type="protein">
            <ProteinExpression sequenceAccessionVersion="O75923" sequenceAccession="O75923" change="p.Arg1693Gln">
              <Expression>O75923:p.Arg1693Gln</Expression>
            </ProteinExpression>
          </HGVS>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.71892312G&gt;A" Assembly="GRCh37">
              <Expression>NC_000002.11:g.71892312G&gt;A</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.71665182G&gt;A" Assembly="GRCh38">
              <Expression>NC_000002.12:g.71665182G&gt;A</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_008694.1" sequenceAccession="NG_008694" sequenceVersion="1" change="g.216560G&gt;A">
              <Expression>NG_008694.1:g.216560G&gt;A</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130455.2" sequenceAccession="NM_001130455" sequenceVersion="2" change="c.5081G&gt;A">
              <Expression>NM_001130455.2:c.5081G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001123927.1" sequenceAccession="NP_001123927" sequenceVersion="1" change="p.Arg1694Gln">
              <Expression>NP_001123927.1:p.Arg1694Gln</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130976.2" sequenceAccession="NM_001130976" sequenceVersion="2" change="c.5036G&gt;A">
              <Expression>NM_001130976.2:c.5036G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001124448.1" sequenceAccession="NP_001124448" sequenceVersion="1" change="p.Arg1679Gln">
              <Expression>NP_001124448.1:p.Arg1679Gln</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130977.2" sequenceAccession="NM_001130977" sequenceVersion="2" change="c.5099G&gt;A">
              <Expression>NM_001130977.2:c.5099G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001124449.1" sequenceAccession="NP_001124449" sequenceVersion="1" change="p.Arg1700Gln">
              <Expression>NP_001124449.1:p.Arg1700Gln</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130978.2" sequenceAccession="NM_001130978" sequenceVersion="2" change="c.5141G&gt;A">
              <Expression>NM_001130978.2:c.5141G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001124450.1" sequenceAccession="NP_001124450" sequenceVersion="1" change="p.Arg1714Gln">
              <Expression>NP_001124450.1:p.Arg1714Gln</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130979.2" sequenceAccession="NM_001130979" sequenceVersion="2" change="c.5171G&gt;A">
              <Expression>NM_001130979.2:c.5171G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001124451.1" sequenceAccession="NP_001124451" sequenceVersion="1" change="p.Arg1724Gln">
              <Expression>NP_001124451.1:p.Arg1724Gln</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130980.2" sequenceAccession="NM_001130980" sequenceVersion="2" change="c.5129G&gt;A">
              <Expression>NM_001130980.2:c.5129G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001124452.1" sequenceAccession="NP_001124452" sequenceVersion="1" change="p.Arg1710Gln">
              <Expression>NP_001124452.1:p.Arg1710Gln</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130981.2" sequenceAccession="NM_001130981" sequenceVersion="2" change="c.5192G&gt;A">
              <Expression>NM_001130981.2:c.5192G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001124453.1" sequenceAccession="NP_001124453" sequenceVersion="1" change="p.Arg1731Gln">
              <Expression>NP_001124453.1:p.Arg1731Gln</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130982.2" sequenceAccession="NM_001130982" sequenceVersion="2" change="c.5174G&gt;A">
              <Expression>NM_001130982.2:c.5174G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001124454.1" sequenceAccession="NP_001124454" sequenceVersion="1" change="p.Arg1725Gln">
              <Expression>NP_001124454.1:p.Arg1725Gln</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130983.2" sequenceAccession="NM_001130983" sequenceVersion="2" change="c.5144G&gt;A">
              <Expression>NM_001130983.2:c.5144G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001124455.1" sequenceAccession="NP_001124455" sequenceVersion="1" change="p.Arg1715Gln">
              <Expression>NP_001124455.1:p.Arg1715Gln</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130984.2" sequenceAccession="NM_001130984" sequenceVersion="2" change="c.5102G&gt;A">
              <Expression>NM_001130984.2:c.5102G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001124456.1" sequenceAccession="NP_001124456" sequenceVersion="1" change="p.Arg1701Gln">
              <Expression>NP_001124456.1:p.Arg1701Gln</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130985.2" sequenceAccession="NM_001130985" sequenceVersion="2" change="c.5132G&gt;A">
              <Expression>NM_001130985.2:c.5132G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001124457.1" sequenceAccession="NP_001124457" sequenceVersion="1" change="p.Arg1711Gln">
              <Expression>NP_001124457.1:p.Arg1711Gln</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130986.2" sequenceAccession="NM_001130986" sequenceVersion="2" change="c.5039G&gt;A">
              <Expression>NM_001130986.2:c.5039G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001124458.1" sequenceAccession="NP_001124458" sequenceVersion="1" change="p.Arg1680Gln">
              <Expression>NP_001124458.1:p.Arg1680Gln</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001130987.2" sequenceAccession="NM_001130987" sequenceVersion="2" change="c.5195G&gt;A" MANESelect="true">
              <Expression>NM_001130987.2:c.5195G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001124459.1" sequenceAccession="NP_001124459" sequenceVersion="1" change="p.Arg1732Gln">
              <Expression>NP_001124459.1:p.Arg1732Gln</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_003494.4" sequenceAccession="NM_003494" sequenceVersion="4" change="c.5078G&gt;A" MANEPlusClinical="true">
              <Expression>NM_003494.4:c.5078G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_003485.1" sequenceAccession="NP_003485" sequenceVersion="1" change="p.Arg1693Gln">
              <Expression>NP_003485.1:p.Arg1693Gln</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="LRG_845" sequenceAccession="LRG_845">
              <Expression>LRG_845:g.216560G&gt;A</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="LRG_845t2" sequenceAccession="LRG_845t2">
              <Expression>LRG_845t2:c.5195G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="LRG_845p2" sequenceAccession="LRG_845p2" change="p.Arg1732Gln">
              <Expression>LRG_845p2:p.Arg1732Gln</Expression>
            </ProteinExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="LRG_845t1" sequenceAccession="LRG_845t1">
              <Expression>LRG_845t1:c.5078G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="LRG_845p1" sequenceAccession="LRG_845p1" change="p.Arg1693Gln">
              <Expression>LRG_845p1:p.Arg1693Gln</Expression>
            </ProteinExpression>
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification DateLastEvaluated="2023-05-11" DateCreated="2018-05-22" MostRecentSubmission="2024-02-11" NumberOfSubmissions="4" NumberOfSubmitters="3">
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description>Pathogenic/Likely pathogenic</Description>
            <Citation Type="general">
              <ID Source="PubMed">16010686</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">16100712</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">18853459</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">23530687</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">25326637</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">25868377</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">26060040</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">2606004</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">27066573</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">27647186</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">28403181</ID>
            </Citation>
            <DescriptionHistory Dated="2022-05-15">
              <Description>Conflicting classifications of pathogenicity</Description>
            </DescriptionHistory>
            <DescriptionHistory Dated="2018-08-04">
              <Description>Uncertain significance</Description>
            </DescriptionHistory>
            <DescriptionHistory Dated="2018-05-25">
              <Description>no classification for the single variant</Description>
            </DescriptionHistory>
            <ConditionList>
              <TraitSet ID="9586" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="9484" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">Dysferlinopathy</ElementValue>
                    <XRef ID="Dysferlinopathy/2379" DB="Genetic Alliance" />
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Qualitative or quantitative defects of dysferlin</ElementValue>
                    <XRef ID="MONDO:0016145" DB="MONDO" />
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">Dysferlinopathy includes a spectrum of muscle disease characterized by two major phenotypes: Miyoshi muscular dystrophy (MMD) and limb-girdle muscular dystrophy type 2B (LGMD2B); and two minor phenotypes: asymptomatic hyperCKemia and distal myopathy with anterior tibial onset (DMAT). MMD (median age of onset 19 years) is characterized by muscle weakness and atrophy, most marked in the distal parts of the legs, especially the gastrocnemius and soleus muscles. Over a period of years, the weakness and atrophy spread to the thighs and gluteal muscles. The forearms may become mildly atrophic with decrease in grip strength; the small muscles of the hands are spared. LGMD2B is characterized by early weakness and atrophy of the pelvic and shoulder girdle muscles in adolescence or young adulthood, with slow progression. Other phenotypes in this spectrum are scapuloperoneal syndrome and congenital muscular dystrophy. Asymptomatic hyperCKemia is characterized by marked elevation of serum CK concentration only. DMAT is characterized by early and predominant distal muscle weakness, particularly of the muscles of the anterior compartment of the legs.</Attribute>
                    <XRef ID="NBK1303" DB="GeneReviews" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="2003" />
                    <XRef ID="2003" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301480</ID>
                    <ID Source="BookShelf">NBK1303</ID>
                  </Citation>
                  <XRef ID="207073" DB="Orphanet" />
                  <XRef ID="C2931687" DB="MedGen" />
                  <XRef ID="MONDO:0016145" DB="MONDO" />
                </Trait>
              </TraitSet>
              <TraitSet ID="1848" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="2959" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Miyoshi muscular dystrophy 1</ElementValue>
                    <XRef ID="MONDO:0024545" DB="MONDO" />
                    <XRef ID="C118846" DB="NCI" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Preferred">MMD1</ElementValue>
                    <XRef Type="MIM" ID="254130" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="public definition">Dysferlinopathy includes a spectrum of muscle disease characterized by two major phenotypes: Miyoshi muscular dystrophy (MMD) and limb-girdle muscular dystrophy type 2B (LGMD2B); and two minor phenotypes: asymptomatic hyperCKemia and distal myopathy with anterior tibial onset (DMAT). MMD (median age of onset 19 years) is characterized by muscle weakness and atrophy, most marked in the distal parts of the legs, especially the gastrocnemius and soleus muscles. Over a period of years, the weakness and atrophy spread to the thighs and gluteal muscles. The forearms may become mildly atrophic with decrease in grip strength; the small muscles of the hands are spared. LGMD2B is characterized by early weakness and atrophy of the pelvic and shoulder girdle muscles in adolescence or young adulthood, with slow progression. Other phenotypes in this spectrum are scapuloperoneal syndrome and congenital muscular dystrophy. Asymptomatic hyperCKemia is characterized by marked elevation of serum CK concentration only. DMAT is characterized by early and predominant distal muscle weakness, particularly of the muscles of the anterior compartment of the legs.</Attribute>
                    <XRef ID="NBK1303" DB="GeneReviews" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="keyword">Miyoshi Distal Myopathy</Attribute>
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301480</ID>
                    <ID Source="BookShelf">NBK1303</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="AAN, 2017">
                    <ID Source="PubMed">25313375</ID>
                    <ID Source="pmc">4206155</ID>
                  </Citation>
                  <XRef ID="45448" DB="Orphanet" />
                  <XRef ID="C4551973" DB="MedGen" />
                  <XRef ID="MONDO:0024545" DB="MONDO" />
                  <XRef Type="MIM" ID="254130" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="1850" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="2988" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2B</ElementValue>
                    <XRef ID="Limb-girdle+muscular+dystrophy%2C+type+2B/4237" DB="Genetic Alliance" />
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2B</ElementValue>
                    <XRef ID="MONDO:0009676" DB="MONDO" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Muscular dystrophy, limb-girdle, type 3</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 2</ElementValue>
                    <XRef Type="MIM" ID="253601" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0003" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0012" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0004" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0017" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0016" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0006" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0013" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0005" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0008" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0009" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0019" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0020" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0007" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0021" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0014" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603009.0022" DB="OMIM" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Alternate">LGMD3</ElementValue>
                    <XRef Type="MIM" ID="253601" DB="OMIM" />
                  </Symbol>
                  <Symbol>
                    <ElementValue Type="Preferred">LGMDR2</ElementValue>
                    <XRef Type="MIM" ID="253601" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="8574" />
                    <XRef ID="8574" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="public definition">Dysferlinopathy includes a spectrum of muscle disease characterized by two major phenotypes: Miyoshi muscular dystrophy (MMD) and limb-girdle muscular dystrophy type 2B (LGMD2B); and two minor phenotypes: asymptomatic hyperCKemia and distal myopathy with anterior tibial onset (DMAT). MMD (median age of onset 19 years) is characterized by muscle weakness and atrophy, most marked in the distal parts of the legs, especially the gastrocnemius and soleus muscles. Over a period of years, the weakness and atrophy spread to the thighs and gluteal muscles. The forearms may become mildly atrophic with decrease in grip strength; the small muscles of the hands are spared. LGMD2B is characterized by early weakness and atrophy of the pelvic and shoulder girdle muscles in adolescence or young adulthood, with slow progression. Other phenotypes in this spectrum are scapuloperoneal syndrome and congenital muscular dystrophy. Asymptomatic hyperCKemia is characterized by marked elevation of serum CK concentration only. DMAT is characterized by early and predominant distal muscle weakness, particularly of the muscles of the anterior compartment of the legs.</Attribute>
                    <XRef ID="NBK1303" DB="GeneReviews" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301480</ID>
                    <ID Source="BookShelf">NBK1303</ID>
                  </Citation>
                  <XRef ID="268" DB="Orphanet" />
                  <XRef ID="C1850889" DB="MedGen" />
                  <XRef ID="MONDO:0009676" DB="MONDO" />
                  <XRef Type="MIM" ID="253601" DB="OMIM" />
                </Trait>
              </TraitSet>
            </ConditionList>
          </GermlineClassification>
        </Classifications>
        <XRefList>
          <XRef ID="CA351294" DB="ClinGen" />
          <XRef ID="O75923#VAR_024870" DB="UniProtKB" />
          <XRef Type="rs" ID="779987458" DB="dbSNP" />
          <XRef Type="Interpreted" ID="424774" DB="ClinVar" />
        </XRefList>
        <AlleleFrequencyList>
          <AlleleFrequency Value="0.00001" Source="Exome Aggregation Consortium (ExAC)" />
          <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
        </AlleleFrequencyList>
      </SimpleAllele>
      <Name>NM_003494.3(DYSF):c.[3516_3517delTT];[5078G&gt;A]</Name>
      <VariationType>CompoundHeterozygote</VariationType>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression>
            <Expression>NM_003494.3:c.[3516_3517delTT];[5078G&gt;A]</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </Genotype>
    <RCVList>
      <RCVAccession Title="NM_003494.3(DYSF):c.[3516_3517delTT];[5078G&gt;A] AND multiple conditions" Accession="RCV000198403" Version="2">
        <ClassifiedConditionList TraitSetID="10241">
          <ClassifiedCondition DB="MedGen" ID="C1850889">Autosomal recessive limb-girdle muscular dystrophy type 2B</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1847532">Distal myopathy with anterior tibial onset</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4551973">Miyoshi muscular dystrophy 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2013-08-06" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2013-08-06" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-10-11" MostRecentSubmission="2015-10-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Likely pathogenic</Description>
        <ConditionList>
          <TraitSet ID="10241" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2959" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Miyoshi muscular dystrophy 1</ElementValue>
                <XRef ID="MONDO:0024545" DB="MONDO" />
                <XRef ID="C118846" DB="NCI" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MMD1</ElementValue>
                <XRef Type="MIM" ID="254130" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dysferlinopathy includes a spectrum of muscle disease characterized by two major phenotypes: Miyoshi muscular dystrophy (MMD) and limb-girdle muscular dystrophy type 2B (LGMD2B); and two minor phenotypes: asymptomatic hyperCKemia and distal myopathy with anterior tibial onset (DMAT). MMD (median age of onset 19 years) is characterized by muscle weakness and atrophy, most marked in the distal parts of the legs, especially the gastrocnemius and soleus muscles. Over a period of years, the weakness and atrophy spread to the thighs and gluteal muscles. The forearms may become mildly atrophic with decrease in grip strength; the small muscles of the hands are spared. LGMD2B is characterized by early weakness and atrophy of the pelvic and shoulder girdle muscles in adolescence or young adulthood, with slow progression. Other phenotypes in this spectrum are scapuloperoneal syndrome and congenital muscular dystrophy. Asymptomatic hyperCKemia is characterized by marked elevation of serum CK concentration only. DMAT is characterized by early and predominant distal muscle weakness, particularly of the muscles of the anterior compartment of the legs.</Attribute>
                <XRef ID="NBK1303" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Miyoshi Distal Myopathy</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301480</ID>
                <ID Source="BookShelf">NBK1303</ID>
              </Citation>
              <Citation Type="general" Abbrev="AAN, 2017">
                <ID Source="PubMed">25313375</ID>
                <ID Source="pmc">4206155</ID>
              </Citation>
              <XRef ID="45448" DB="Orphanet" />
              <XRef ID="C4551973" DB="MedGen" />
              <XRef ID="MONDO:0024545" DB="MONDO" />
              <XRef Type="MIM" ID="254130" DB="OMIM" />
            </Trait>
            <Trait ID="2988" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2B</ElementValue>
                <XRef ID="MONDO:0009676" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 2</ElementValue>
                <XRef Type="MIM" ID="253601" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0020" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0021" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0022" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2B</ElementValue>
                <XRef ID="Limb-girdle+muscular+dystrophy%2C+type+2B/4237" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, limb-girdle, type 3</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LGMDR2</ElementValue>
                <XRef Type="MIM" ID="253601" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LGMD3</ElementValue>
                <XRef Type="MIM" ID="253601" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dysferlinopathy includes a spectrum of muscle disease characterized by two major phenotypes: Miyoshi muscular dystrophy (MMD) and limb-girdle muscular dystrophy type 2B (LGMD2B); and two minor phenotypes: asymptomatic hyperCKemia and distal myopathy with anterior tibial onset (DMAT). MMD (median age of onset 19 years) is characterized by muscle weakness and atrophy, most marked in the distal parts of the legs, especially the gastrocnemius and soleus muscles. Over a period of years, the weakness and atrophy spread to the thighs and gluteal muscles. The forearms may become mildly atrophic with decrease in grip strength; the small muscles of the hands are spared. LGMD2B is characterized by early weakness and atrophy of the pelvic and shoulder girdle muscles in adolescence or young adulthood, with slow progression. Other phenotypes in this spectrum are scapuloperoneal syndrome and congenital muscular dystrophy. Asymptomatic hyperCKemia is characterized by marked elevation of serum CK concentration only. DMAT is characterized by early and predominant distal muscle weakness, particularly of the muscles of the anterior compartment of the legs.</Attribute>
                <XRef ID="NBK1303" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8574" />
                <XRef ID="8574" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301480</ID>
                <ID Source="BookShelf">NBK1303</ID>
              </Citation>
              <XRef ID="268" DB="Orphanet" />
              <XRef ID="C1850889" DB="MedGen" />
              <XRef ID="MONDO:0009676" DB="MONDO" />
              <XRef Type="MIM" ID="253601" DB="OMIM" />
            </Trait>
            <Trait ID="3419" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Distal myopathy with anterior tibial onset</ElementValue>
                <XRef ID="MONDO:0011721" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DMAT</ElementValue>
                <XRef Type="MIM" ID="606768" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17080" />
                <XRef ID="17080" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="178400" DB="Orphanet" />
              <XRef ID="C1847532" DB="MedGen" />
              <XRef ID="MONDO:0011721" DB="MONDO" />
              <XRef Type="MIM" ID="606768" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="470566" SubmissionDate="2015-05-14" DateLastUpdated="2015-10-11" DateCreated="2015-10-11">
        <ClinVarSubmissionID localKey="53" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000255363" DateUpdated="2015-10-11" DateCreated="2015-10-11" Type="SCV" Version="3" SubmitterName="UCLA Clinical Genomics Center, UCLA" OrgID="505231" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-08-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Lee et al. (JAMA. 2014)</Attribute>
          <Citation>
            <ID Source="PubMed">25326637</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Ethnicity>European Caucasian,African American</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">10</Age>
              <Age Type="maximum" age_unit="years">19</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <NamePlatform>HiSeq</NamePlatform>
              <TypePlatform>exome sequencing</TypePlatform>
              <Citation>
                <ID Source="PubMed">25326637</ID>
              </Citation>
              <MethodType>clinical testing</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory">UCLA Clinical Genomics Center</Attribute>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <Genotype>
          <SimpleAllele>
            <GeneList>
              <Gene Symbol="DYSF" />
            </GeneList>
            <VariantType>Variation</VariantType>
            <AttributeSet>
              <Attribute Type="HGVS">NM_003494.3:c.3516_3517delTT</Attribute>
            </AttributeSet>
            <AttributeSet>
              <Attribute Type="HGVS">NM_003494.3:c.3516_3517delTT</Attribute>
            </AttributeSet>
          </SimpleAllele>
          <SimpleAllele>
            <GeneList>
              <Gene Symbol="DYSF" />
            </GeneList>
            <VariantType>Variation</VariantType>
            <AttributeSet>
              <Attribute Type="HGVS">NM_003494.3:c.5078G&gt;A</Attribute>
            </AttributeSet>
            <AttributeSet>
              <Attribute Type="HGVS">NM_003494.3:c.5078G&gt;A</Attribute>
            </AttributeSet>
          </SimpleAllele>
          <VariationType>CompoundHeterozygote</VariationType>
        </Genotype>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Miyoshi muscular dystrophy 1</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="254130" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Limb-girdle muscular dystrophy, type 2B</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="253601" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Myopathy, distal, with anterior tibial onset</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="606768" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CES</StudyName>
        <SubmissionNameList>
          <SubmissionName>CES</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="470566" TraitType="Disease" MappingType="Name" MappingValue="Myopathy, distal, with anterior tibial onset" MappingRef="Preferred">
        <MedGen CUI="C1847532" Name="Distal myopathy with anterior tibial onset" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="470566" TraitType="Disease" MappingType="Name" MappingValue="Limb-girdle muscular dystrophy, type 2B" MappingRef="Preferred">
        <MedGen CUI="C1850889" Name="Autosomal recessive limb-girdle muscular dystrophy type 2B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="470566" TraitType="Disease" MappingType="Name" MappingValue="Miyoshi muscular dystrophy 1" MappingRef="Preferred">
        <MedGen CUI="C4551973" Name="Miyoshi muscular dystrophy 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

